See also this year's filing and all EDGAR filings for this company.
PDF Report 0001811764_2023_POINT_Biopharma_Global_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001811764, POINT Biopharma Global Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 530,822,730 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 31,380,576 |
| 3 | remainder_Assets | 16,119,430 |
| 4 | LiabilitiesCurrent | 79,738,440 |
| 5 | LiabilitiesNoncurrent | 10,178,147 |
| 6 | remainder_Liabilities | 1,452,356 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,006,876 |
| 9 | ResearchAndDevelopmentExpense | 82,050,392 |
| 10 | remainder_Expenses | 31,292,875 |
| 11 | remainder_Revenues | 226,579,563 |
| 12 | remainder_NetIncome | 4,063,793 |
| 13 | remainder_ComprehensiveNetIncome | -456,851 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 578,322,736 |
| 1 | Liabilities | 91,368,943 |
| 2 | Expenses | 132,350,143 |
| 3 | Revenues | 226,579,563 |
| 4 | StockholdersEquity | 486,953,793 |
| 5 | NetIncome | 98,293,213 |
| 6 | ComprehensiveNetIncome | 98,064,788 |
| 7 | BaseVar | 516,571,014 |
| 8 | EconomicCapitalRatio | 2.79 |
Edgar->Model Mapping
Feature Distribution
Change over Time
